Categories Earnings, Health Care

AngioDynamics (ANGO): Q2 2020 Earnings Snapshot

— AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected.

— Net sales remained flat at $70 million, vs. $71.2 million expected.

— US net sales grew 1.8% to $55.6 million.

— International net sales increased 5.6% to $14.4 million.

— Oncology net sales rose 5.1% to $16.1 million.

— Vascular Interventions and Therapies net sales grew 0.6% to $31.2 million.

— Vascular Access net sales fell 4% to $22.8 million.

— FY2020 net sales are expected to be $280-286 million.  

— FY2020 adjusted EPS is expected to be $0.10-0.15.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Earnings Preview: What to look for when Broadcom (AVGO) reports Q1 results

Broadcom, Inc. (NASDAQ: AVGO) will be releasing its first-quarter results next week. Over the years, the company constantly broadened its portfolio beyond semiconductors to areas like enterprise software solutions, a

Here’s a look at Lowe’s (LOW) expectations for the near term and ahead

Shares of Lowe’s Companies, Inc. (NYSE: LOW) were up over 1% on Friday. The stock has gained 19% over the past three months. The home improvement retailer saw sales and

TJX Companies (TJX) Q4 2024 profit jumps on strong revenue growth

The TJX Companies, Inc. (NYSE: TJX) has reported a double-digit increase in net income for the fourth quarter of 2024 when the fashion retailer's net sales grew 13%. Fourth-quarter sales

Add Comment
Viewing Highlight